//
Kim Sharp
Eleni Ladikou
Emma Kennedy
Andrea Pepper
Chris Pepper
Brighton and Sussex Medical School,Brighton,Royaume-uni
Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien
Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien
Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien
Brighton and Sussex Medical School,Brighton,Storbritannien
Brighton and Sussex Medical School, Brighton, United Kingdom
Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien
Brighton and Sussex Medical School,Brighton,Vereinigtes Königreich
Brighton and Sussex Medical School,Brighton,Соединённое Королевство
Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien
Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien
Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien
Brighton and Sussex Medical School, Brighton, United Kingdom
Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Соединённое Королевство
Brighton and Sussex Medical School,Brighton,Vereinigtes Königreich
Brighton and Sussex Medical School, Brighton, United Kingdom
United States
United Kingdom
N/A
Oncology (ONC)
Acute myelocytic leukemia
Cluster of Differentiation 34
Cluster of Differentiation 38
Proto-oncogene tyrosine-protein kinase ROS
Cluster of Differentiation 47
KIT Proto-Oncogene, Receptor Tyrosine Kinase
Human Leukocyte Antigen – DR isotype
Thy-1 Cell Surface Antigen
N/A
N/A
N/A
N/A
N/A
N/A
N/A